Fennec Pharmaceuticals Inc.

United States of America


 
Total IP 25
Total IP Rank # 58,361
IP Activity Score 2.3/5.0    28
IP Activity Rank # 28,084
Stock Symbol
ISIN CA31447P1009
Market Cap. 171M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

12 4
2 0
3 0
4
 
Last Patent 2024 - Anhydrous sodium thiosulfate and...
First Patent 2018 - Method for reducing ototoxicity ...
Last Trademark 2023 - PEDMARQSI
First Trademark 2017 - PEDMARK

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Pharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity fr...
Invention Therapeutic uses for sodium thiosulfate formulations. Described herein is anhydrous sodium thios...
2023 Invention Anhydrous sodium thiosulfate and formulations thereof. Described herein is anhydrous sodium thio...
2022 G/S Patient administration services, namely, enrolling patients in the patient assistance programs of...
Invention Therapeutic uses for sodium thiosulfate formulations. Described herein is anhydrous sodium thiosu...
Invention Therapeutic uses for sodium thiosulfate and formulations. Described herein is anhydrous sodium th...
Invention Anhydrous sodium thiosulfate and formulations thereof. Described herein is anhydrous sodium thios...
G/S Patient advocacy services, namely, promoting public awareness of pharmaceutical discount opportun...
2019 Invention Formulations of anhydrous sodium thiosulfate. Described herein is anhydrous sodium thiosulfate, ...
Invention Formulations of anhydrous sodium thiosulfate. Described herein is anhydrous sodium thiosulfate, m...
2018 Invention Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy. Desc...